FR2121529A1 - Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid - Google Patents

Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid

Info

Publication number
FR2121529A1
FR2121529A1 FR7147771A FR7147771A FR2121529A1 FR 2121529 A1 FR2121529 A1 FR 2121529A1 FR 7147771 A FR7147771 A FR 7147771A FR 7147771 A FR7147771 A FR 7147771A FR 2121529 A1 FR2121529 A1 FR 2121529A1
Authority
FR
France
Prior art keywords
compsns
cyclobenzaprine
oxyphenbutazone
chlordiazepoxide
phenylbutazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7147771A
Other languages
English (en)
French (fr)
Other versions
FR2121529B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2121529A1 publication Critical patent/FR2121529A1/fr
Application granted granted Critical
Publication of FR2121529B1 publication Critical patent/FR2121529B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7147771A 1971-01-05 1971-12-31 Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid Granted FR2121529A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10413971A 1971-01-05 1971-01-05
US11060971A 1971-01-28 1971-01-28
US12224771A 1971-03-08 1971-03-08
US13147171A 1971-04-05 1971-04-05

Publications (2)

Publication Number Publication Date
FR2121529A1 true FR2121529A1 (en) 1972-08-25
FR2121529B1 FR2121529B1 (OSRAM) 1975-03-14

Family

ID=27493365

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7147771A Granted FR2121529A1 (en) 1971-01-05 1971-12-31 Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid

Country Status (1)

Country Link
FR (1) FR2121529A1 (OSRAM)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722938A (en) * 1984-12-26 1988-02-02 Analgesic Associates Methods for using musculoskeletal relaxants
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
US4923898A (en) * 1984-12-26 1990-05-08 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
WO2001012174A1 (en) * 1999-08-13 2001-02-22 Vela Pharmaceuticals Inc. Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
WO2001012175A1 (en) * 1999-08-13 2001-02-22 Vela Pharmaceuticals Inc. Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine
WO2002058620A3 (es) * 2001-01-26 2002-12-12 Osmotica Costa Rica Sa Composiciones farmaceuticas que contienen un inhibidor de cox-ii y un relajante muscular

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722938A (en) * 1984-12-26 1988-02-02 Analgesic Associates Methods for using musculoskeletal relaxants
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
US4923898A (en) * 1984-12-26 1990-05-08 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US6358944B1 (en) 1999-08-13 2002-03-19 Vela Pharmaceuticals, Inc. Methods and compositions for treating generalized anxiety disorder
WO2001012175A1 (en) * 1999-08-13 2001-02-22 Vela Pharmaceuticals Inc. Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine
WO2001012174A1 (en) * 1999-08-13 2001-02-22 Vela Pharmaceuticals Inc. Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
GB2368283A (en) * 1999-08-13 2002-05-01 Vela Pharmaceuticals Inc Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
GB2368522A (en) * 1999-08-13 2002-05-08 Vela Pharmaceuticals Inc Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine
US6395788B1 (en) 1999-08-13 2002-05-28 Vela Pharmaceuticals, Inc. Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
US6541523B2 (en) 1999-08-13 2003-04-01 Vela Pharmaceuticals, Inc. Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine
ES2192156A1 (es) * 1999-08-13 2003-09-16 Vela Pharmaceuticals Inc Composiciones de uso para tratar o prevenir alteraciones del sueño usando dosis muy bajas de ciclobenzaprina.
ES2212737A1 (es) * 1999-08-13 2004-07-16 Vela Pharmaceuticals Inc. Ciclobenzaprina para tratar trastornos de ansiedad generalizada y composiciones de la misma.
WO2002058620A3 (es) * 2001-01-26 2002-12-12 Osmotica Costa Rica Sa Composiciones farmaceuticas que contienen un inhibidor de cox-ii y un relajante muscular

Also Published As

Publication number Publication date
FR2121529B1 (OSRAM) 1975-03-14

Similar Documents

Publication Publication Date Title
Rogers The essence of psychotherapy: A client-centered view.
FR2121529A1 (en) Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid
NL170921C (nl) Werkwijze voor het bereiden van geneesmiddelpreparaten voor een therapie of profylaxie van precancerosen en carcinomen.
Moyer Internal impulses to aggression.
NL159089B (nl) Werkwijze voor de bereiding van een tert.butyloxycarbonylinsuline, werkwijze voor de bereiding van geneesmiddelen met verlengde bloedsuikerspiegel-verlagende werking, alsmede aldus gevormd geneesmiddel.
NL150096B (nl) Werkwijze voor het bereiden van gesubstitueerde (alpha)-fenoxycarbonzuurderivaten met cholesterol- of lipidegehalte verlagende werking, werkwijze voor het bereiden van een therapeutisch preparaat en gevormd therapeutisch preparaat.
DK132157C (da) Selvsperrende indstillingsmekanisme til et vinkelindstillingsbeslag mellem sede og ryglen pa en stol
NO140823C (no) Analogifremgangsmaate til fremstilling av alfa-sulfo-3-tienylmetylpenicillin og salter derav med terapeutisk aktivitet
Miller Some animal experiments pertinent to the problem of combining psychotherapy with drug therapy.
ZA71951B (en) Dosage units for the administration of medicaments and the like
Grinspoon et al. Pharmacotherapy combined with other treatment methods.
Isaksson et al. A comparison between imipramine and protriptyline in the treatment of depressed out-patients.
FI48578C (fi) Menetelmä keskushermostoa stimuloivien diaryylisyklopropaanijohdannais ten valmistamiseksi.
NL145760B (nl) Werkwijze ter bereiding van anthelmintisch werkzame geneesmiddelen en diervoeders en aldus verkregen gevormde geneesmiddelen en diervoeders.
Bidder et al. Modifications of electroconvulsive therapy.
Rachman Behavior therapy and psychodynamics.
Fluegelman et al. Experimental treatment of depression with anafranil (Monochlorimipramine).
Peissker CRITICAL STRESS FOR CROSS SLIP AND STACKING FAULT ENERGIES OF COPPER BASE MIXED CRYSTALS.
Wyatt Effects of MAO inhibitors and parachlorophenylalanine in longitudinal sleep studies.
NL139453B (nl) Werkwijze ter bereiding van een geneesmiddel voor toepassing in de mens- en diergeneeskunde.
SAITO 54. The Clinical Study on Steroid Therapy in Neurosurgery
NL145840B (nl) Werkwijze voor de bereiding van difenylpropylaminederivaten met kransslagaderverwijdende, bloeddrukverlagende respectievelijk hoeststillende werking, werkwijze voor de bereiding van therapeutische preparaten die deze verbindingen bevatten, alsmede gevormde therapeutische preparaten verkregen volgens deze werkwijze.
FR2782M (fr) Nouveaux médicaments actifs sur le systeme nerveux autonome et possédant des propriétés anorexigenes et stimulantes sur le systeme nerveux central.
NL155556B (nl) Werkwijze voor de bereiding van een geneesmiddel met progestatieve werking door een 3-keto-(delta)4-11,13-dimethyl-17-acetoxysteroide in een voor therapeutische toepassing geschikte toedieningsvorm te brengen, de gevormde geneesmiddelen, alsmede werkwijze voor de bereiding van daarvoor geschikte verbindingen.
Kutsuruba et al. The treatment of patients with affective disorders with ethylnorantiphen.

Legal Events

Date Code Title Description
ST Notification of lapse